10/03/2023at 10:04

Bernie Sanders introduces bill to cap insulin prices at USD 20

One vial of insulin shouldn’t cost more than USD 20, says the senator and chair of the US senate health committee.

Bernie Sanders, sen. of Vermont, chair of the US Senate Committee on Health | Photo: Mary F. Calvert

by marketwire, translated by daniel pedersen

Chair of the US Senate Committee on Health and Senator Bernie Sanders presented on Thursday a proposal that would cap insulin prices at USD 20 per vial.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices
For subscribers
Analyst: Eli Lilly's insulin price drop is politically motivated
For subscribers
Eli Lilly to lower insulin prices by 70% in US
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Antibiotic Dicillin has infected Danish and Icelandic patients Antibiotikummet Dicillin har smittet både danskere og islændinge med multiresistente bakterier, som patienterne sandsynligvis skal leve med resten af livet. | Foto: Lægemiddelstyrelsen / Pr

Pharma & biotech

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.

For subscribers

Både danskere og islændinge har nu multiresistente bakterier i kroppen efter at have spist antibiotikummet Dicillin. | Photo: Lægemiddelstyrelsen / Pr

Other

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

For subscribers

Pharma & biotech

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

For subscribers

Pharma & biotech

Zealand Pharma presents positive early-stage results for weight-loss candidate

For subscribers

Pharma & biotech

Genmab promotes senior VP for strategy to executive management

For subscribers

Medtech

Ambu wins European approval of two fifth-generation bronchoscopes

For subscribers

California moves forward with making biosimilar insulin

The state has entered a contract with generic drugmaker Civica to make insulin products that are interchangeable with those of Novo Nordisk, Sanofi, and Eli Lilly.

For subscribers

Pharma & biotech

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Sandoz ends its collaboration with the secret CMO that made the contaminated antibiotic product and cannot rule out other drugs could be infected with multi-resistant bacteria.

For subscribers

Bernie Sanders, Vermont Senator and chair of the US senate health committee, urges fellow insulin makers Novo Nordisk and Sanofi to lower prices like Eli Lilly | Foto: Anna Moneymaker/AFP/Ritzau Scanpix

Pharma & biotech

Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices

The chair of the senate health committee says “unacceptable corporate greed” is why insulin prices have risen 1,000% since 1996 in letters addressed to CEOs of Novo Nordisk and Sanofi.

For subscribers

Bernie Sanders introduces bill to cap insulin prices at USD 20

Read the whole article

With your free trial you get:

Get full access for you and your coworkers

Related articles:

Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices

Analyst: Eli Lilly's insulin price drop is politically motivated

Eli Lilly to lower insulin prices by 70% in US

Sign up for our newsletter

Front page now

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Denmark: Violation of good manufacturing practice is source of contaminated antibiotic

Analyst: New Novo Nordisk data sets the bar high for diabetes pills

Zealand Pharma presents positive early-stage results for weight-loss candidate

Genmab promotes senior VP for strategy to executive management

Ambu wins European approval of two fifth-generation bronchoscopes

Further reading

California moves forward with making biosimilar insulin

Sandoz severs ties with European CMO – Dicillin permanently withdrawn from market

Bernie Sanders urges Novo Nordisk and Sanofi to follow Eli Lilly's example: Drop insulin prices

Jobs